Introduction
Integrins are heterodimeric transmembrane receptors for extracellular matrix (ECM) proteins which promote adhesion, migration, and proliferation of cells by recognizing binding motifs in ECM proteins. 1 The integrin family that recognizes endogenous arginine-glycine-aspartic acid (RGD) ligands are of great therapeutic interest, playing a role in thrombosis, fibrosis, and cancer. In cancer, integrins mediate adhesion events during various stages of the disease, i.e. angiogenesis, tumor growth and progression, invasion, and metastasis. [2] [3] [4] [5] In particular, the α V β 3 integrin receptor, which recognizes the RGD sequence of vitronectin, [6] [7] has a critical role in tumorinduced angiogenesis and metastasis formation. [8] [9] [10] [11] [12] [13] Therefore, RGD-containing peptides and peptidomimetics [14] [15] [16] [17] as well as RGD-mimetics 1a are widely studied as antagonists to suppress the events mediated by this integrin and as shuttles for targeted delivery of drugs and diagnostics. 18 To date, a few low-nanomolar-affinity α V β 3 receptor binders which present the RGD system installed on rigid hetero-and carbacyclic scaffolds have been reported. For example, bicyclic lactams, [19] [20] [21] γ-aminocyclopentanecarboxylic acids, 22 cis-β-aminocyclopropanecarboxylic acids, 23 4-aminoprolines, 24, 25 bifunctional diketopiperazines, 26 morpholine derivatives, 27 ,28 7-aminoazocinone-2-carboxylate derivatives, 29 and both aminoand hydroxy-substituted 2,3-methanopipecolic acids (or CPA, cyclopropane pipecolic acid), the latter recently reported by us, [30] [31] [32] have all been used to generate potent α V β 3 integrin ligands. Because of our interest in the synthesis [33] [34] [35] [36] and biomedical applications [30] [31] [32] of pipecolic acid derivatives, in order to further expand the array of available scaffolds which can be grafted into the key α V β 3 -recognizing peptide sequence, we decided to synthesize and evaluate 5-aminopipecolic acid, the homologue of 4-aminoproline, 24 , and/or χ 3 torsion angles, but also as rigid β-, γ-or δ-amino acids. While some examples of peptidomimetics incorporating 4-aminopicolic acids 3 and 4 as α-amino acids exist, 37, 38 their regioisomers have rarely been introduced in amino acid sequences to generate conformationally restricted peptides or embedded in other bioactive compounds, and not many efforts have been devoted to their synthesis. 39 In particular, the synthesis of enantiopure trans 5-aminopipecolic acid (herein referred as 5-APA) 5, used as a novel chiral PNA monomer, has been reported by Kumar. 40 Racemic trans and cis 5-APAs (5 and 6) were prepared by Dhimane as new conformationally constrained ornithine analogues, as well as intermediates for obtaining arginine analogues with simultaneous restriction of χ i and φ torsion angles. 41 Racemic cis 5-APA 6 was also prepared by Harris 42 and Shono, 43 in both cases as an intermediate in the synthesis of (±)-Slaframine. Therefore, given the paucity of synthetic approaches to enantiopure trans and cis 5-APA 5 and 6, and because of our interest in the incorporation of cis 5-APA in cyclic RGD ligands, we planned a stereodivergent strategy to obtain 5 and 6, suitably protected for peptide synthesis, in enantiopure form.
Results and Discussion

Chemistry
We have recently reported an efficient synthesis of both enantiomers of 4-hydroxypipecolic acid methyl ester derivative 7 (Scheme 1) in gram quantities starting from commercial γ-(hydroxymethyl)butyrolactone 8. In analogy to both Kumar's 40 and Dhimane's 41 syntheses, this substrate is suitable to be converted into both trans and cis 5-APAs 9 and 10 (Scheme 1) by functional and protecting group manipulation, although the installation of the orthogonal exocyclic N-Fmoc and endocyclic N-Boc groups in trans 5-APA 9 required a different strategy. For the synthesis of protected trans 5-APA 9 (Scheme 2) with S absolute configuration at C1, we exhaustively deprotected (1S, 5S)-7 to obtain free amino acid 11. 35 After protection of the N atom as N-Boc, benzylation of the carboxylic group provided ester 12 in 78% yield over two steps. Mesylation of the OH group, followed by nucleophilic displacement by sodium azide in DMF provided trans compound 13 in 65% yield (two steps). Eventually, hydrogenation over 10% Pd/C provided the free amino acid intermediate which was converted into the N-Fmoc protected derivative 9 in 63% yield over two steps and with orthogonal protection suitable for peptide synthesis. For the synthesis of the cis 5-APA, since we wanted to introduce it in a cyclic peptide as a δ-amino acid, we decided to leave the original protection on the heterocycle N atom unaltered (Scheme 3). A first inversion of configuration was carried out on 7 by a Mitsunobu reaction which provided trans acetate 14. This acetate could not be separated from a byproduct but, after hydrolysis, alcohol 15 35 was obtained in pure form by chromatography, in 63% yield over two steps. As before, the alcohol was converted into azide 16 (73% over two steps) and the methyl ester group of the latter hydrolyzed under basic conditions to give 17 (100%). This allowed us to reduce the azido to amino group without the risk of lactamisation during the hydrogenation step. 
Biological Studies
The RGD-containing peptidomimetic 22 was tested for its capacity to compete with vitronectin for the binding to α V β 3 integrin expressed in high level by M21 human melanoma cells as reported, 30, 32 in comparison to the reference RGD ligand cyclo[RGDf(N-Me)V] (Cilengitide) 45 (Table 1) . 47 The comparatively lower inhibition activity of 22 measured on M21 cell line could be due to the presence of other integrins which are inhibited by Cilengitide. 17 We have already assessed by flow cytometry analysis that the M21 cell line, besides high level of α V β 3 , expresses also low level (4%) of α v β 5 heterodimer. 32 In any case, as will be discussed later, these data suggest that the 5-APA structure induces a significant conformational asset towards the optimal presentation of the pharmacophoric groups of the ligand.
Conformational Analysis
H NMR analysis
The structure and connectivity of cyclopeptide 22 was unambiguously assigned by means of mono-and bidimensional cross-peaks along the Arg-Gly-Asp sequence, although AspNH has a NOE cross-peak only with one of the two CHα protons of Gly. Two strong contacts, very useful for the determination of the putative preferred conformation in solution, were found between ArgNH and the CHα of the pipecolic acid (i.e. 2-H) as well as with equatorial 3-H of the pipecolic ring, suggesting an "outward" orientation of the N-H bond. Moreover, 5-APA-NH seems oriented "inward" as it shows a strong cross-peak with equatorial 6-H (and a weaker one with 4-H), possibly forming an H-bond with the "inward" oriented pipecolic acid C=O group, as corroborated by the lowest temperature coefficient (−3.56 ppb K −1 ) for this amide proton.
As a further indication of the existence of a preferred conformation in aqueous solution, the two diastereotopic CHα of Gly resonate as highly separated dds (4.04 and 3.50 ppm) and, moreover, only one of them (i.e. that at 4.04 ppm) shows a cross-peak with the AspNH.
Computational analysis
The conformational preference of compound 22 was also evaluated by replica exchange molecular dynamic (REMD) simulations, 48 using a previously optimized protocol 49 that proved to be successful in determining the preferred conformation of similar cyclopeptides. 30 The simulation consisted in 12 replica of 400 ns, with temperatures spanning from 300 to 860 K, without using any restraint derived from the observed NOE's. Figure S2 (ESI).
As a comparison, the same protocol was applied to Cilengitide, taken as a reference. 17 The most representative conformations of compound 22 and Cilengitide are shown in Figure 3 , while selected geometrical parameters are reported in Table 2 .
It can be observed that the obtained conformation for 22 perfectly matches the putative preferred conformation inferred by the NMR analysis ( Figure 3A ). As suggested by the latter, the six-membered ring is in a twist-boat conformation and the C5-NH bond is pseudoaxially oriented with the 5-APA-NH pointing slightly inward (C5-C6-N-H dihedral (dih1) = 33.0±15.7 deg.) and forming the aforementioned H-bond with the pipecolic acid C=O group (d1 = 2.3±0.3 Å). Its distance with 6-H eq (d2) is 2.6±0.2 Å, and with 4-H eq (d3) is 3.0±0.2 Å, in accordance with the NOE correlations and intensities. The C Arg -N Arg bond is instead oriented outward (N1-C2-C Arg -N Arg dihedral (dih2) = 174.7±9.6 deg.) with a distance between Arg NH and 2-H (d4) of 2.5±0.2 Å and between Arg NH and 3-H eq of (d5) 2.2±0.2 Å, consistently with the NOEs found, with the pipecolic acid C=O group forming a dihedral angle of -5.3 deg with the C2-N1 bond.
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Please do not adjust margins All the other distances are in accordance with the NOEs correlations (see Table S1 , ESI), too. In particular, as found by NMR analysis, the AspNH is close to one (the pro-S, accordingly to calculations) of the Gly CHα protons (d6 = 2.4±0.2 Å). Because of its importance for the biological activity, the measured distance between the Cβ atoms of Asp and Arg (d7) in the global minimum conformer of 22 resulted in a value of 8.4±0.2 Å, which is comparable to the corresponding distance (8.9 Å) measured in the X-ray structure of the α V β 3 -Cilengitide complex, 50 and very close to the value obtained by REMD simulations followed by cluster analysis of Cilengitide (8.5±0.5 Å) ( Figure 3B ). Similarly, the analysis of the φ and ψ dihedrals belonging to the RGD portion showed a good match between compound 22 and Cilengitide in both the free form, obtained by REMD, and bound form found in the crystal structure (Table  2) . Interestingly, the lower standard deviations of the compared dihedrals and the higher population of the main conformational cluster (93.3% vs 64.4% for compound 22 and Cilengitide, respectively) suggest that the 5-APA scaffold is particularly effective in maintaining the RGD portion rigid and close to the bioactive conformation. To confirm this observation, we performed 100 ns of classical MD simulation in explicit water, starting from the representative conformation of the main cluster obtained from the REMD simulations of compound 22 and of Cilengitide (in this last case, starting from the conformation found in the crystal structure provided comparable results). The obtained trajectories were processed to perform a root-mean-squaredfluctuation (RMSF) analysis, which provides a picture of the atomic fluctuations during the simulation time and, consequently, of the molecule flexibility. A representation of the average fluctuations of the backbone atoms of the bioactive RGD portions of compound 22 and Cilengitide is provided in Figure 4 . As expected, it can be observed that compound 22 is significantly more rigid, particularly at the Arg C=O and Asp Cα and C=O. Finally, we ought to evaluate compound 22 in the binding site of the α V β 3 receptor. The models were generated starting from the crystal structure of Cilengitide in complex with the α V β 3 receptor as described in the Experimental section. The comparison of the geometries of compound 22 and Cilengitide in the binding site of α V β 3 is shown in Figure 5 . 
Conclusions
In conclusion, a stereodivergent strategy to obtain enantiopure cis and trans 5-aminopipecolic acids (5-APA) in a suitably protected form for peptide synthesis has been devised starting from known 5-hydroxypipecolic acid as the common precursor. The two isomers were efficiently obtained in 38% and 32% overall yield, respectively, in seven steps. To demonstrate their usefulness in peptidomimetics, the cis isomer was embedded as a δ-amino acid in a cyclic RGDcontaining sequence (compound 22). A 10% aqueous solution of Na 2 CO 3 (640 μL) was added to a suspension of amino acid (52 mg, 0.21 mmol) in THF (510 μL) and the resulting mixture cooled to 0 °C. After the addition of a solution of Fmoc-OSu (72 mg, 0.21 mmol) in THF (1.5 mL), the ice bath was removed and the mixture was vigorously stirred at room temperature for 16 h. The solvent was evaporated under reduced pressure and the residue was taken up in EtOAc (3 mL). The organic solution was washed once with satd. NH 4 Cl (3 mL) and, after separation of the phases, the aqueous one was extracted with EtOAc (5 x 3 mL). The aqueous layer was then acidified down to pH 2 by addition of aqueous 0.5 N HCl, and extracted again with EtOAc (5 x 3 mL). The combined organic extracts were dried over Na 2 SO 4 . After filtration and evaporation of the solvent, the crude residue was purified by flash chromatography (MeOH/CH 2 Cl 2 1:20, R f 0.14) and pure compound 9 ( 
Synthesis of (2S,5S)-5-(9-Fluorenylmethoxycarbonylamino)-1-(methoxycarbonyl)piperidine-2-carboxylic acid [(-)-10] (2S,5R)-Dimethyl 5-Hydroxypiperidine-1,2-dicarboxylate [15].
A solution of 7 (372 mg, 1.71 mmol) and Ph 3 P (673 mg, 2.56 mmol) in dry THF (13 mL) was added to a solution of diisopropyl azodicarboxylate (DIAD) (505 µL, 2.56 mmol) and acetic acid (147 µL, 2.56 mmol) in dry THF (13 mL), cooled to 0 °C and under nitrogen atmosphere. After 1 h, the solvent was removed under reduced pressure and the residue taken up in a n-hexane-Et 2 O 1:1 mixture (20 mL). After filtration on a Celite pad and evaporation of the solvent, the crude residue was purified by flash chromatography (n-hexane/EtOAc, 2:1; R f 0.30) to afford acetate 14 (in a 1.2:1 ratio with a residual impurity of reduced DIAD) as a colourless oil: A solution of 14 in dry MeOH (10 mL) was cooled to 0 °C, under nitrogen atmosphere, and MeONa (93 mg, 1.73 mmol) was added. After 6 h, glacial acetic acid (769 µL) was added and the solvent evaporated. The residue was diluted with water (45 mL), the product extracted with EtOAc (6 x 60 mL) and the combined organic extracts dried over Na 2 SO 4 . After filtration and evaporation of the solvent, the crude residue was purified by flash chromatography (n-hexane/EtOAc, 2:3; R f 0.18) to afford 15 (236 mg, 63% over two steps) as a colourless oil. Spectroscopic data are identical to those already reported in the literature. 95 (m, 1 H, both rotamers), 1.78-1.66 (m, 1 H, both rotamers), 1.57-1.46 (m, 1 H, . DEPBT (334 mg, 1.12 mmol) and DIPEA (194 µL, 1.12 mmol) were added under nitrogen atmosphere to a solution of 10 (237 mg, 0.56 mmol) in anhydrous THF (4 mL) cooled to 0°C, and the resulting mixture was allowed to warm to room temperature. After 15 min the reaction was cooled again to 0°C, and H-Arg(Mtr)-Gly-OBn (387 mg, 0.73 mmol) was added. The ice bath was removed and the mixture was stirred at 35°C (external) for 4 days. The mixture was then diluted with EtOAc (90 mL), washed with satd NH 4 Cl (2 x 23 mL), satd NaHCO 3 (2 x 23 mL), and finally with H 2 O (2 x 23 mL). The organic extract was dried over Na 2 
Computational studies
Material and methods
Parameterization of nonstandard residues. Charge parameterization for (2S,5S)-5-APA, protected at N1 as a methyl carbamate, was performed using the R.E.D. procedure. 51 The structure was capped by a acetyl and a
NHMe at the 5-amino and at the C-2 carboxy group, respectively, and subjected to a conformational search using the low mode method and the MMFF94x force field, implemented in MOE (other parameters were left as default). 52 The two lowest energy conformations were used for charge parameterization. Moreover, for each conformation, two different orientations were used to derive RESP charges. The Gaussian09 software was used for quantum mechanical calculations, 53 at the HF/6-31G* level, as requested for force field compatibility. REMD simulations. Starting conformations of compound 22 were generated by a preliminary conformational search performed with MOE. 52 Independent REMD runs were started from two different conformations, selected to maximize geometrical difference. The ff96 force field coupled with the GB-OBC(II) solvent model 54 was adopted accordingly to a protocol previously applied to similar synthetic peptides. 30,49d Geometries were minimized by 500 steps of steepestdescendant followed by 500 steps of conjugated-gradient and twelve replicas were run at 300. . 55 A time step of 0.002 ps and an infinite cut-off for electrostatic were adopted. Exchanges were attempted every 2 ps and an acceptance rate above 50% was observed. To evaluate convergence, the 300 K trajectories were subjected to a cluster analysis every 50 ns. The simulation was considered converged when the population of the three principal clusters differed by less than 15% between consecutive 50 ns batches. After 300 ns of simulation, no significant differences were observed in the population of the three main clusters and in their representative geometries. Moreover, no significant differences were observed between results obtained by independent simulations starting from divergent geometries. REMD calculations and cluster analyses were performed with the pmemd.MPI and cpptraj executables of the Amber16/AmberTools17 packages, respectively. 56 A maximum of 10 clusters was requested, using the averagelinkage algorithm, the pairwise mass-weighted RMSD on backbone heavy atoms as a metric and sampling one frame every 4 ps. MD simulations. Classical MD simulations were performed by starting from the reference geometry of the most populated cluster, as obtained from cluster analysis. In the case of Cilengitide, the simulations were also repeated by starting from the crystal structure reported in ref. 50 . The system was prepared using tleap, setting an octahedral solvent box of TIP3P water extending up to 10 Å from the solute. Volume and density were equilibrated trough subsequent NVT (100 ps) and NPT (100 ps) simulations, where the solute was kept restrained. The system was then geometry minimized and gently heated up to the final temperature of 300 K. Further equilibration was performed by NVT (200 ps) and NPT (1000 ps) simulations, where solute restraints were gradually removed. A NVT production run of 100 ns was then performed using a cutoff of 8 Å was for electrostatics and PME for longrange interactions. 57 All bonds involving hydrogens atoms were constrained by using the SHAKE algorithm. 58 Production runs were performed on a GPU card using the pmemd.cuda engine 59 and trajectories were analyzed using cpptraj (AmberTools17).
56
Modelling of ligand-receptor complexes. The ligand-receptor models for compound 22 and Cilengitide were obtained with MOE 52 starting from the 1L5G pdb file. 50 Only chains B (the receptor monomer) and C (Cilengitide) were maintained and the structure was processed with the Structure Preparation module and protonated accordingly to a pH = 7. The representative geometry of compound 22, as obtained by REMD simulations followed by cluster analysis, was manually docked to α V β 3 by superposing the Cα of the RGD portion to the corresponding atoms of the co-crystallized Cilengitide, that was then removed. The resulting geometry was then minimized up to a gradient of 0.1 kcal/mol/Å 2 , using the Amber10EHT force field and the Born solvation model for water, keeping the receptor backbone atoms restrained. For comparison, the same protocol was applied to the complex of Cilengitide.
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